Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
Noosa News21 hours agoQueensland’s new home buyer scheme under fire over mortgage stress risks
-
Noosa News17 hours agoFamily of slain mum seek urgent entry to Australia to care for her sons
-
General20 hours agoPricier supermarkets sour on grocery cost survey
-
Noosa News20 hours agoQueensland government moves censure motion, condemns opposition absences from parliament